Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$227,478,282
+$35,663,194 QoQ
Shares Held
903,983
+2.5% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#143
of 4,145 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vanguard Investments Australia, Ltd. holds $1,647,249,369 across 11 Drug Manufacturers - General names. ABBV ranks #3 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
409,709 | $491,417,306 | |
| 2 | JNJ |
Johnson & Johnson
|
1,153,630 | $292,987,411 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
903,983 | $227,478,282 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,263,127 | $162,311,819 | |
| 5 | AZN |
Astrazeneca PLC
|
769,786 | $145,966,821 | |
| 6 | AMGN |
Amgen Inc
|
275,433 | $99,739,797 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
634,457 | $80,157,297 | |
| 8 | PFE |
Pfizer Inc
|
2,906,592 | $69,990,735 |
All Filings in ABBV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $227,478,282 | 903,983 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $191,815,088 | 881,949 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||